InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: Amatuer17 post# 223604

Sunday, 04/08/2018 11:59:13 PM

Sunday, April 08, 2018 11:59:13 PM

Post# of 403015
The post is specious and maybe a bit disingenuous with a rhetorical device about how many BPs showed interest the past 5 years. Well, 5 years ago the company was still a Phase 1 biopharma. At the time the CEO stated the best deals come after Phase 2 trials, and the very best deals occur at Phase 3.The company is now Phase 2/3 with one more trial report on the way. The company has only just entered what he said would be his strongest negotiating position with a 3rd drug on the cusp of the same. Anyone who has been here for 5 years should know all this, and in a fair argument and criticism would acknowledge that the CEO has been clear about his intentions to court BP only at this juncture. Just this past February he announced ~20 CDAs, which is in keeping with what he said 5 years ago about what would be the conditions for eventual licensing agreements.

We have seen how many companies are interested in last 5 years - talk is cheap - actions talk


* Never borrow to invest.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News